Breaking News

Selvita Adds Antibody Discovery and Development Capabilities

Will open a new research site in Wroclaw, Poland, with over 400 square meters of state-of-the-art labs along with all necessary infrastructure.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Selvita S.A. entered a strategic initiative to significantly expand its services portfolio and enter the field of biologic drug discovery and development, adding comprehensive therapeutic antibody discovery and development capabilities.   The company will employ a team of experts specializing in the discovery and development of therapeutic antibodies and rent fully equipped state-of-the-art laboratories.   Selvita will offer a suite of fully comprehensive antibody-related services for therap...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters